Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Reprod Toxicol ; 23(2): 175-81, 2007 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-17095185

RESUMEN

The present study was carried out to investigate the effects of diphenyl diselenide, (PhSe)(2), on embryo-fetal development. Dams were treated subcutaneously with 1.5, 3.0 and 6.0 mg/kg (PhSe)(2) from days 6 to 15 of pregnancy. After cesarean section at gestation day (GD) 20, external and skeletal abnormalities were evaluated. A decrease in maternal body weight gain was found in (PhSe)(2) groups, indicating maternal toxicity. There was a reduction in the fetal weight and in crown-rump (CR) length of fetuses at three doses tested. The occipito-nasal length decreased in fetuses from dams exposed to 3.0 mg/kg (PhSe)(2). Signs of delayed ossification in the skull, sternebrae and limbs were observed in all (PhSe)(2) groups, revealing a relation between morphological alterations and growth retardation in fetuses, but none of the changes appeared to be dose-dependent. Exposure of dams to (PhSe)(2) resulted in altered placental morphology that may have contributed to adverse reproductive outcomes. We concluded that (PhSe)(2) is toxic to dams and induces developmental delay of the fetal skeleton, but does not cause externally visible malformations in rat fetuses, in this experimental procedure.


Asunto(s)
Anomalías Inducidas por Medicamentos , Derivados del Benceno/toxicidad , Desarrollo Embrionario/efectos de los fármacos , Desarrollo Fetal/efectos de los fármacos , Compuestos de Organoselenio/toxicidad , Teratógenos/toxicidad , Animales , Huesos/efectos de los fármacos , Largo Cráneo-Cadera , Relación Dosis-Respuesta a Droga , Femenino , Retardo del Crecimiento Fetal , Peso Fetal/efectos de los fármacos , Inyecciones Subcutáneas , Exposición Materna , Placenta/efectos de los fármacos , Placenta/patología , Embarazo , Ratas , Ratas Wistar , Teratógenos/clasificación , Aumento de Peso/efectos de los fármacos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA